News & Events

Dear All,   Please click here to see the final version of the Position Statement on Hepatitis B Virus Screening and Reactivation Prophylaxis for Patients Planned to Receive Immunosuppressive SACT…

For information – please click here to see the final version of the National SACT Protocols: Options Appraisal. https://www.ukchemotherapyboard.org/publications The UK Chemotherapy Board will discuss the next steps at our next meeting. Kind regards,…

Please click here to see the BOPA recommendations for the use of Tall Man lettering for SACT within the UK. Also available here: https://www.bopa.org.uk/resources/bopa-recommendations-of-the-use-of-tall-man-lettering-for-systemic-anti-cancer-treatments-sact-in-the-united-kingdom-v1-0/  Kind regards, The BOPA  Executive Committee 

Please see the minutes for all the BOPA Executive TCON meetings HERE

Friday 4th February 2022 marks World Cancer Day, a global initiative led by the Union for International Cancer Control (UICC). To mark this important day, the University of Chester Research…

The 2022 Awards and Bursaries round is open from Monday 24th January and closes at 1pm on Wednesday 20th April The BOPA-PRUK Research Award is a great opportunity for UK-based pharmacy professionals…

Don’t forget to register for the 2022 UK Interdisciplinary Breast Cancer Symposium to be held on-line on Monday 24 January and Tuesday 25 January. Registration for this meeting is free.…

Recent Publications from our members are below: Suzanne Frank (Specialist Breast Cancer Pharmacist at The Christie NHS Foundation Trust) – White Paper on the Value of Time Savings for Patients…

The Clinician FAQS and guidance on COVID-19 vaccine for patient receiving SACT. Version 6.0. Updated 21st December 2021 is now available on the UKCB website here: https://www.ukchemotherapyboard.org/publications.  This updated guidance…

The British Oncology Pharmacy Association is committed to champion equality, diversity and inclusion (EDI) in order to create a positive environment for all. Therefore, we would like to invite interested…

Recent Publications from our members are below: Faye Coe – Average duration of prior treatment lines predicts clinical benefit to eribulin chemotherapy in patients with metastatic breast cancer | SpringerLink…

Please see the minutes for all the BOPA Executive TCON meetings HERE